Treatment of feline hypertension with transdermal amlodipine: A pilot study

Journal of the American Animal Hospital Association

Volumn 43, Issue 3, 2007, Pages 149-156

  Helms, Scott Roderick ^a  

^a Unifour Veterinary Referrals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FELIDAE;

AMLODIPINE; ANTIHYPERTENSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOAVAILABILITY; BIOLOGICAL MODEL; BLOOD; BLOOD PRESSURE; CAT; CAT DISEASE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HYPERTENSION; INTRADERMAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PILOT STUDY; PROSPECTIVE STUDY;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; AMLODIPINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL AVAILABILITY; BLOOD PRESSURE; CAT DISEASES; CATS; FEMALE; HYPERTENSION; MALE; MODELS, BIOLOGICAL; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 34249705748     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0430149     Document Type: Article

References (29)

1. Maggio F, DeFrancesco TC, Atkins CE, et al. Ocular lesions associated with systemic hypertension in cats: 69 cases (1985-1998). J Am Vet Med Assoc 2000;217:695-702.
2. Henik RA. Systemic hypertension and its management. Vet Clin North Am Small Anim Pract 1997;27:1355-1372.
3. Sander C, Horauf A, Reusch C. Indirect blood pressure measurement in cats with diabetes mellitus, chronic nephropathy and hypertrophic cardiomyopathy. Tierarztl Prax Ausg K Klientiere Heimtiere 1998;26:110-118.
4. Binns SH, Sisson DD, Buoscio DA, et al. Doppler ultrasonographic, oscillometric sphygmomanometric, and photoplethysmographic techinques for noninvasive blood pressure measurement in anesthetized cats. J Vet Intern Med 1995;9:405-414.
5. Belew AM, Barlett T, Brown SA. Evaluation of the white-coat effects in cats. J Vet Intern Med 1999; 13:134-142.
6. Henik RA, Snyder PS, Volk LM. Treatment of systemic hypertension in cats with amlodipine besylate. J Am Anim Hosp Assoc 1997;33:226-234.
7. Snyder PS. Amlodipine: a randomized, blinded clinical trial in 9 cats with systemic hypertension. J Vet Intern Med 1998;12:157-162.
8. Elliott J, Barber PJ, Syme HM, et al. Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract 2001;42:122-129.
9. Mathur S, Syme H, Brown CA, et al. Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency. Am J Vet Res 2002;63:833-839.
10. Villarino N, Landoni MF. Transdermal drug delivery: a new frontier in the administration of therapeutic drugs to veterinary species. Vet J 2006;172:200-201.
11. Magnusson BM, Walters KA, Roberts MS. Veterinary drug delivery: potential for skin penetration enhancement. Adv Drug Deliv Rev 2001;50:205-227.
12. Mills, PC, Cross SE. Transdermal drug delivery: basic principles for the veterinarian. Vet J 2006;172:218-233.
13. Guy RH, Hadgraft J, Bucks DA. Transdermal drug delivery and cutaneous metabolism. Xenobiotica 1987;17:325-343.
14. Brown MB, Martin GP, Jones SA, et al. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 2006;13:175-187.
15. Cal K. Aqueous solubility of liquid monoterpenes at 293K and relationship with calculated log P value. Yakugaku. Zasshi 2006;126: 307-309.
16. Haas CE, Lin L, Cloen D, et al. Omeprazole absorption from a compounded transdermal formulation in healthy volunteers. J Am Pharm Assoc (Wash DC) 2005;45:473-478.
17. Kanikkannan N, Kandimalla K, Lamba SS, et al. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 2000;7:593-608.
18. Degim T, Hadgraft J, Ilbasmis S, et al. Prediction of skin penetration using artificial neural network (ANN) modeling. J Pharm Sci 2003;92:656-664.
19. Murdan S. Organogels in drug delivery. Expert Opin Drug Deliv 2005;2:489-505.
20. Benson HA. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2005;2:23-33.
21. Hoffman SB, Yoder AR, Trepanier LA. Bioavailability of transdermal methimazole in pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther 2002;25:189-193.
22. Willis-Goulet HS, Schmidt BA, Nicklin CF, et al. Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study. Vet Dermatol 2003;14:83-89.
23. Ciribassi J, Luescher A, Pasloske KS, et al. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats. Am J Vet Res 2003;64:994-998.
24. Mealey KL, Peck KE, Bennett BS, et al. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats. J Vet Intern Med 2004;18:43-46.
25. Bennett N, Papich MG, Hoenig M, et al. Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats. Am J Vet Res 2005;66:581-588.
26. Hoffmann G, Marks SL, Taboada J, et al. Transdermal methimazole treatment in cats with hyperthyroidism. J Feline Med Surg 2003;5:77-82.
27. Sartor LL, Trepanier LA, Kroll MM, et al. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism. J Vet Intern Med 2004;18:651-655.
28. Sennello KA, Schulman RL, Prosek R, et al. Systolic blood pressure in cats with diabetes mellitus. J Am Vet Med Assoc 2003;223: 198-201.
29. Stopher DA, Beresford AP, Macrae PV, et al. The metabolism and pharmacokinetics of amlodipine in humans and animals. J Cardiovasc Pharmacol 1988;12:S55-S59.